PMID- 17498710 OWN - NLM STAT- MEDLINE DCOM- 20071108 LR - 20131121 IS - 1556-5653 (Electronic) IS - 0015-0282 (Linking) VI - 88 IP - 4 DP - 2007 Oct TI - Erectile dysfunction: does insulin resistance play a part? PG - 771-8 AB - OBJECTIVE: To review MEDLINE literature for correlations between insulin resistance and erectile dysfunction (ED). DESIGN: MEDLINE literature review (1966 to present). SETTING: Academic medical center. PATIENT(S): None. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): None. RESULT(S): Erectile dysfunction affects more than half of men over the age of 40. Fortunately, most men with ED can be successfully treated with phosphodiesterase 5A (PDE-5) inhibitors, which up-regulate the vasodilatory effects of nitric oxide (NO). Insulin resistance affects 25% of U.S. adults and increases to a 60% occurrence in individuals who are overweight. Endothelial dysfunction, which is associated with insulin resistance states, can cause disturbances in the subcellular signaling pathways required for NO production. Because endothelial production of NO and insulin sensitivity are positively related in healthy humans, the relationships among insulin resistance, NO, and ED are the target of this review of MEDLINE literature. CONCLUSION(S): Insulin resistance states are characterized by defective vascular NO production and impaired insulin-induced vasodilation, both of which are likely to cause ED. Diagnosing and treating insulin resistance should be part of the initial management plan for ED. Future studies concerning the cause and effect relationship of insulin resistance and ED should be implemented. FAU - Trussell, J C AU - Trussell JC AD - Division of Urology, Penn State Milton S. Hershey Medical Center and Penn State College of Medicine, Hershey, PA 17033-0850, USA. jtrussell@psu.edu FAU - Legro, Richard S AU - Legro RS LA - eng GR - K24 HD01476/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review DEP - 20070511 PL - United States TA - Fertil Steril JT - Fertility and sterility JID - 0372772 RN - 0 (Adrenergic beta-Antagonists) RN - 0 (Gonadal Steroid Hormones) RN - 0 (Insulin) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 1.14.13.39 (Nitric Oxide Synthase) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) SB - IM MH - Adrenergic beta-Antagonists/therapeutic use MH - Adult MH - Aged MH - Animals MH - Erectile Dysfunction/drug therapy/*etiology MH - Gonadal Steroid Hormones/physiology MH - Humans MH - Insulin/physiology MH - Insulin Resistance/*physiology MH - Male MH - Middle Aged MH - Nitric Oxide/physiology MH - Nitric Oxide Synthase/antagonists & inhibitors/physiology MH - Phosphatidylinositol 3-Kinases/metabolism MH - Proto-Oncogene Proteins c-akt/physiology RF - 72 EDAT- 2007/05/15 09:00 MHDA- 2007/11/09 09:00 CRDT- 2007/05/15 09:00 PHST- 2006/10/19 00:00 [received] PHST- 2007/01/17 00:00 [revised] PHST- 2007/01/17 00:00 [accepted] PHST- 2007/05/15 09:00 [pubmed] PHST- 2007/11/09 09:00 [medline] PHST- 2007/05/15 09:00 [entrez] AID - S0015-0282(07)00274-9 [pii] AID - 10.1016/j.fertnstert.2007.01.116 [doi] PST - ppublish SO - Fertil Steril. 2007 Oct;88(4):771-8. doi: 10.1016/j.fertnstert.2007.01.116. Epub 2007 May 11.